You are here

P&T® Journal contents for January 2007

Features

Dr. Stefanacci explains the new rules for Medicare’s Part D drug benefit for the year 2007 and offers strategies for reducing out-of-pocket expenses for beneficiaries.
Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD
The authors present the results of a brief audience participation survey of 601 psychiatrists about their practices of prescribing antidepressants and discuss the use of first-line, second-line, and third-line treatment options.
Thomas L. Schwartz, MD, and Ayesha Rashid, MD
Patients were able to achieve reductions of blood pressure, glycosylated hemoglobin, and low-density lipoprotein-cholesterol, according to the authors, because physicians adhered to national guidelines and spent “quality time” with these patients.
Shan Wang, PharmD, RPh, Nicholas Berbari, MD, David Choi, DO, James McNamara, PharmD Candidate, Martin Feuerman, MS, Kathryn Bucci, PharmD, and Brian Malone, MS, RPh
Meeting Highlights
Dr. Goldenberg discusses the current status of targeted therapies for colorectal cancer; novel biologic agents that target angiogenesis and growth factors; a monoclonal antibody for colon and pancreatic cancer; and kinase-targeted drugs for gastrointestinal stromal tumors.
Marvin M. Goldenberg, PhD, RPh, MS
Meeting Highlights
The authors review the cardiovascular risks of commonly used painkillers and present the latest findings on acute myocardial infarction, atrial fibrillation in hypertension, cardiovascular disease in diabetes patients, non–ST-segment elevation in acute coronary syndrome, and familial hypercholesterolemia. The controversial torcetrapib/atorvastatin (Lipitor) combination is also discussed.
Lawrence M. Prescott, PhD, and Sharon L. Prescott

Departments

Editorial
David Nash, MD, MBA, describes the Pacific Northwest Economic Region (PNWER), an alliance of states and territories that offers publicly funded health insurance in Canada.
David Nash, MD, MBA
Medication Errors
Matthew Grissinger, RPh, FASCP, explains how “systems thinking” can be used to prevent errors like the tragic accident in 2001 that killed a young MRI patient.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
Stephen Barlas discusses the challenges that face the new FDA Commissioner and Congress in 2007, especially the need to strengthen the FDA’s MedWatch system and its reporting of adverse drug events.
Stephen Barlas
P&T presents the latest studies and information about FDA approvals, drug indications, and industry updates.
Drug Forecast
The authors review varenicline (Chantix) for smoking cessation.
Marilena S. Antonopoulos, PharmD, and Christine M. Bercume, PharmD